The GLP-1 Podcast Show - Dr. Caroline Apovian: GLP-1 Game Changers | Ep. 6

In this episode of The GLP 1 Podcast Show, Dr. Caroline Apovian, Professor of Medicine at Harvard Medical School and Co-Director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital, speaks with Areesha Moiz about the scientific evolution of obesity treatment. The discussion examines obesity as a chronic disease, the mechanisms behind GLP 1 receptor agonists, and how these therapies compare with lifestyle intervention and metabolic surgery. It also addresses stigma, cardiovascular outcomes, appropriate patient selection, and the future of access to highly effective obesity medications. Listen now on all major platforms!

What you’ll learn: 

• Obesity as chronic disease
• GLP-1 mechanisms explained
• Comparing treatment modalities
• Stigma and regulatory barriers
• Access and future therapies

Meet the guest:

Dr. Caroline Apovian is Professor of Medicine at Harvard Medical School and Co Director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital. A founding leader in obesity medicine, her research focuses on adipose tissue inflammation, cardiovascular risk, metabolic surgery, and pharmacotherapy for obesity. 

Hear Dr. Caroline Apovian on The GLP-1 Podcast Show, available on all major platforms.
Connect with our guest on Social Media: LinkedIn

Liked this one? Don’t stop now. Here’s what we think you’ll love!